Home » Lilly Loses Bid to End Revived Zyprexa UK Patent Case
Lilly Loses Bid to End Revived Zyprexa UK Patent Case
Eli Lilly, whose best-selling schizophrenia drug Zyprexa survived a United Kingdom court challenge by generic makers two years ago, lost a bid to dismiss another lawsuit over the medicine’s patent in Britain.
Indianapolis Business Journal
Indianapolis Business Journal
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May